INTEGRA LIFESCIENCES HOLDINGS CORP Deferred Income Tax Liabilities, Net
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had Deferred Income Tax Liabilities, Net of $3.47 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-07-29
- 2026-06-30: Deferred Income Tax Liabilities, Net $3.47M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $6.14M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $5.66M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $58.28M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $3.47M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $6.14M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $5.66M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $58.28M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $60.06M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $57.58M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $60.83M 10-K · filed 2026-02-26 |
| 2024-09-30 | $68.94M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $86.53M 10-Q · filed 2024-07-29 |
| 2024-03-31 | $31.43M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $35.32M 10-K · filed 2025-02-25 |
| 2023-09-30 | $74.45M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $70.65M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $61.69M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $63.34M 10-K · filed 2024-02-28 |
| 2022-09-30 | $69.74M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $61.29M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $56.63M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $45.79M 10-K · filed 2023-02-22 |
| 2021-09-30 | $70.33M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $63.45M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $65.28M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $16.19M 10-K · filed 2022-02-24 |
| 2020-09-30 | $27.78M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $21.26M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $24.22M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $36.55M 10-K · filed 2021-02-23 |
| 2019-09-30 | $59.73M 10-Q · filed 2019-10-25 |
| 2019-06-30 | $53.09M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $57.66M 10-Q · filed 2019-04-29 |
| 2018-12-31 | $57.78M 10-K · filed 2020-02-21 |
| 2018-09-30 | $73.00M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $73.31M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $72.88M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $65.13M 10-K · filed 2019-02-26 |
| 2017-09-30 | $128.63M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $131.25M 10-Q · filed 2017-07-26 |
| 2016-12-31 | $148.94M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |